menu
    • menu

    Company profile for Recordati

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INTERMEDIATES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European c...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RecordatiItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Matteo Civitali, 1 20148 Milan
    Telephone
    Telephone
    +39 02487871
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.recordati.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/recordati/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI WW Frankfurt

    Not Confirmed

    envelop Contact Supplier

    CPhI WW Frankfurt

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    "50 Years of Innovation: Mikart

    mic"50 Years of Innovation: Mikart's legacy and what's next in CDMO excellence"

    This week, SpeakPharma interviews Michael Kallelis, CEO of Mikart, a leading contract development and manufacturing organization (CDMO) celebrating its 50th anniversary in the pharmaceutical industry. Based in the United States, Mikart has built a reputation for technical expertise, flexible business terms, and specialized capabilities in pharmaceutical development services. In this exclusive interview, Kallelis discusses how Mikart maintains its competitive edge through its Pharmaceutical Development Services team, quality control framework, and commitment to customized business solutions. Kallelis also explores the company's focus on liquid suspensions manufacturing, driven by growing demand from aging populations and pediatric patients, and explains how Mikart balances traditional family business values with modern innovation. HIGHLIGHTS// celebrating its 50th anniversary/ reputation for technical expertise/ how Mikart maintains its competitive edge Mikart is celebrating 50 years in business this year — what are some of the major milestones that have shaped the company's journey?  Over our 50-year history, we've celebrated many memorable milestones, but one of the most significant in recent years has been achieving our growth objectives. This success was driven by the strategic expansion of our Pharmaceutical Development Services team, the completion of full aggregate serialization in our packaging department, modernization of our IT systems, enhanced productivity, and our ability to attract both new and returning customers. HIGHLIGHTS// expansion of our Pharmaceutical Development Services team/ completion of full aggregate serialization/ attract both new and returning customers How has Mikart maintained its competitive edge in a constantly evolving pharmaceutical landscape? Our customers consistently tell us that what sets us apart is our technical expertise, high service level, and flexible, customized business terms. At the core of our competitiveness is our focus on Pharmaceutical Development Services (PDS). Mikart's PDS opinion leaders are actively engaged in business development and form early, collaborative relationships with our customers' technical teams. From the outset, our prospects and clients work directly with Mikart's experienced formulation chemists, analytical method developers, and process-oriented engineers to design robust, reproducible, and efficient processes. This hands-on development approach is supported by a comprehensive quality control testing framework — covering raw material testing, in-process checks, on-site microbiological testing, and in-house stability studies. Oversight is provided by our robust Quality Management System, managed by a dedicated Quality Assurance and Regulatory Affairs team. The result is disciplined problem-solving, timely FDA submissions, and a "right-first-time" philosophy that accelerates time-to-market. We operate with a strong sense of urgency and consistently deliver a high level of customer satisfaction. What truly differentiates Mikart is our commitment to customized business terms that eliminate common roadblocks seen with other CDMOs. Our secret sauce is our exceptional service and flexibility in helping our customers bring innovative medicines to patients. HIGHLIGHTS// technical expertise, high service level/ flexible, customized business terms/ comprehensive quality control testing framework/ dedicated Quality Assurance and Regulatory Affairs team/ timely FDA submissions/ accelerates time-to-market What capabilities or services does Mikart offer today that didn't exist 10 or 20 years ago? Mikart was an early leader in serialization, implementing full capabilities well ahead of the industry timeline. This proactive approach has kept our packaging team in high demand. We also upgraded our tablet compression equipment to enhance both speed and reliability. To support growing development needs, we invested in new lab-scale development equipment, unit dose cup filling, sachet packaging, low-humidity suites, and a brand-new suite dedicated to closed-system manufacturing of liquids and suspensions. Most recently, we launched a multi-million dollar expansion of our packaging lines to support higher-speed tablet filling, powder-in-bottle formats, and new liquid fill capabilities. HIGHLIGHTS// early leader in serialization/ upgraded our tablet compression equipment/ multi-million dollar expansion of our packaging lines Why are liquid suspensions becoming such a key focus, and how is Mikart positioned? Formulating suspensions is a complex process that requires specialized expertise and equipment. According to our customers, few mid-market CDMOs do it well — and Mikart is one of them. There is growing industry demand for high-quality suspension manufacturing, driven by the needs of the aging baby boomer population and pediatric patients. For both groups, swallowing tablets or capsules can be difficult, making oral liquid suspensions a more practical alternative. In addition to being easier to administer, suspensions offer pharmacological advantages and can improve dosing compliance. Enhanced flavoring techniques further improve the patient experience — especially for children and infants — by making medicines more palatable. HIGHLIGHTS// growing industry demand for high-quality suspension manufacturing/ suspensions offer pharmacological advantages/ improve dosing compliance How does Mikart balance tradition with innovation to meet modern customer demands?  At Mikart, we work hard to preserve the values of a traditional family business, even as we continue to modernize. Our goal is to make every customer feel like they are our top priority. Each customer is supported by a dedicated project manager who serves as their primary point of contact, along with direct access to key team members across departments. This structure ensures our customers are never isolated from our subject matter experts and can get timely, accurate answers to their questions. We're also mindful of the "technology trap" — the tendency to pursue every new innovation at the expense of focus and efficiency. Instead, we rely on market data and customer trends to guide our investments, enabling us to concentrate our resources and capital on technologies that meet real market needs. HIGHLIGHTS// customer is supported by a dedicated project manager/ customers are never isolated from our subject matter experts/ we rely on market data and customer trends to guide our investments/ meet real market needs Looking ahead, what's in store for Mikart in the next 5-10 years? Mikart's strategic plan is now in full motion, and with the momentum we've built, 50 percent growth is within reach. This projection is backed by a strong pipeline of annual FDA filings, a growing customer base, and a robust portfolio of active Pharmaceutical Development Services projects. As we grow, we remain committed to delivering exceptional service and continuously evolving to meet the changing needs of our customers. With renewed political emphasis on domestic manufacturing for the US market, we are ideally positioned to support the rapid, cost-effective development and production of high-quality medicines here at home. As we approach our 50th anniversary in the CDMO industry, we celebrate our legacy and look forward with optimism to the opportunities ahead in the next 5 to 10 years. HIGHLIGHTS// 50 percent growth is within reach/ strong pipeline of annual FDA filings 

    Impressions: 2817

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence

    PharmaCompass
    17 Jul 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaIngredients for Innovative FormulationsIngredients for Innovative Formulations

    Ingredients for Innovative Formulations
    Ingredients for Innovative Formulations

    reelIngredients for Innovative Formulations

    This PharmaReel highlights Kirsch Pharma’s expertise in providing premium quality raw materials, custom blends, and tailor-made solutions. With 40+ years of expertise and certified quality (GMP, ISO 9001, FSSC 22000, Halal, Kosher), Kirsch supports pharma, biotech, and nutrition industries worldwide.

    Impressions: 1125

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

    Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

    Precise particle size control has become the cornerstone of modern pharmaceutical manufacturing. With highly potent active pharmaceutical ingredients (HPAPIs) and complex formulations driving unprecedented demand, micronization technology is no longer optional — it's critical. The market reflects this urgency. The global API micronization market will jump from US$ 2.47 billion in 2024 to US$ 3.68 billion by 2030 — a 49 percent surge driven by a robust 6.84 percent CAGR. What's powering this growth? Strategic innovation by industry leaders. Companies like Munit SA, Lonza, Catalent, Veranova, EUROAPI, AGC Pharma Chemicals, Hovione and Coral Drugs aren't just participating — they're defining the future of pharmaceutical particle engineering. The Micronization Landscape: How leading companies are advancing pharmaceutical particle engineering The API micronization space is being shaped by companies with specialized expertise. Munit’s proprietary fluid jet milling technology brings particle sizes down to the 1-micron level — critical for inhalation therapies. In addition, this technology enables precise control over particle size distribution without mechanical impact, making it ideal for heat-sensitive and high-potency APIs. With decades of hands-on experience, Munit ensures batch-to-batch consistency, scalability from R&D to commercial volumes, and full compliance with GMP standards.  Munit offers high-containment isolators — including glove boxes for R&D and half-suit isolators for larger batches — with industry-leading containment levels, limiting airborne drug exposure to as low as 0.025 micrograms per cubic meter. This makes it particularly well-suited for handling highly potent or sensitive compounds, exceeding the capabilities of other commercial-scale players like Catalent, who typically achieve containment levels of 0.05 micrograms per cubic meter or higher. EUROAPI has taken a broad particle engineering approach, offering both micronization and spray drying across multiple dosage routes — oral, inhaled, and parenteral. AGC Pharma Chemical leverages spray drying and amorphous solid dispersion technologies across small molecules, peptides, ADCs, and oligonucleotides, exemplifying the evolving intersection of particle engineering and modern drug delivery innovation. Coral Drugs delivers cutting-edge technology and customization capabilities that tailor particle sizes to specific client requirements across tablets, injectables, and topicals. This dynamic competitive landscape continues to evolve as companies expand capabilities and form strategic partnerships. This year, Dec Group announced the launch of their cutting-edge Micronization Suite, now operational in Brick, New Jersey, while Lonza joined the Centre for Continuous Manufacturing and Advanced Crystallisation, an international research hub, to develop innovative continuous processing and crystallization solutions. Selecting the right micronization partner: Key success factors In a pharmaceutical landscape increasingly defined by complexity, precision, and speed-to-market, the choice of a micronization partner can significantly influence a drug’s success. Among the players in this space, Munit SA has emerged as a trusted and strategic ally for pharmaceutical companies worldwide. But what exactly sets Munit apart in the micronization market? To begin with, Munit SA brings over 60 years of experience in particle size engineering. This legacy is not just a number; it reflects decades of accumulated knowledge, process refinement, and a deep understanding of how particle size impacts drug performance. In an industry where even minor deviations can compromise efficacy or safety, this level of experience is invaluable. It has delivered over 500 successful micronization projects to more than 150 customers globally. At its core, Munit SA is laser-focused on micronization and milling — not as ancillary services, but as its primary mission. Their facilities are designed for processing high-potency APIs, cytotoxic and cytostatic compounds, non-beta-lactam antibiotics, steroids, and controlled substances under stringent containment protocols. The company also handles inhalation products, peptides, biological drugs, generics, and R&D compounds. Whether it's micronization for ophthalmic formulations, transdermal or oral products, Munit offers a tailored approach. It stands as a world-leading provider of micronization services in inhalation powders with particle sizes of 1-5 microns and specialized oncology applications for small molecules. In an increasingly complex global landscape, Munit SA addresses supply chain challenges through its dual-site operational model, with facilities in Switzerland (Jetpharma SA) and Italy (Microchem S.r.l). This strategic setup mitigates risks from regulatory changes, geopolitical tensions, or environmental disruptions, ensuring continuous production and delivery of critical APIs. This resilience makes Munit a trusted partner for companies prioritizing business continuity. Why pharmaceutical companies choose Munit for advanced micronization and milling Munit’s proprietary MC Jet Mill is a testament to its engineering excellence. For heat-sensitive APIs, Munit’s cryogenic micronization process uses liquid nitrogen to cool materials, preventing thermal degradation and preserving the integrity of delicate molecules. This is particularly valuable for biologics and APIs with low melting points, where stability is paramount. Additionally, Munit’s under containment micronization employs advanced systems to safely handle HPAPIs, protecting both operators and the environment while meeting stringent regulatory standards.  Their co-micronization service, which processes APIs alongside excipients, further enhances formulation stability and solubility, offering innovative solutions for complex drug profiles. These capabilities, executed under Good Manufacturing Practices (GMP), make Munit a reliable choice for pharmaceutical companies seeking precision and quality. While micronization is Munit’s flagship, it offers milling services through an array of technologies, each suited to specific needs. The Pin Mill uses a grinding chamber and particle size reduction is achieved due impact against a high-speed pin rotor, producing sizes from 50 to 150 microns. It’s particularly effective for APIs needing improved flow for tableting, offering precise size control that ensures uniformity. The Quadro Co-Mill excels at soft de-lumping and homogenization, using a conical sieve and impeller to gently process powders without altering primary particle sizes. For tougher materials, the HammerMill C-10 employs hammer bars on a rotor to crush particles. State-of-the-Art Particle Engineering: Munit's strategic innovation push delivers next-gen solutions Munit’s leadership in micronization is underpinned by a deliberate and sustained investment in innovation — aimed at building the next generation of particle size engineering. In response to client challenges with condensation and product degradation, Munit developed a proprietary conditioning system that precisely controls humidity and temperature. Engineered with ergonomic design and fluid dynamics principles, their machine represents a qualitative leap in conditioning. Munit's new AIFA-approved Building C transforms the Italian hub's capacity. Equipped for high potent, toxic, cytotoxic, and cytostatic compounds, alongside hormones, it features cutting-edge safety systems and integrated technologies, enabling broader API processing with precision and compliance. Munit has merged quality assurance and regulatory affairs into one strategic unit, streamlining workflows and enhancing client responsiveness during critical validation phases. This delivers tailored regulatory support and accelerates time-to-market. These initiatives position Munit at the forefront of particle size engineering, where state-of-the-art innovation, regulatory excellence, and client-centric design converge to set new industry standards. Our view The API micronization market is projected to grow 49 percent to US$ 3.68 billion by 2030. In this evolving landscape, companies that combine deep technical expertise with operational resilience are positioned to capture the greatest value. Munit SA exemplifies this winning formula.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2679

    https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers

    #Phispers by PHARMACOMPASS
    10 Sep 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Recordati Reports Strong Momentum in H1 2025: Revenue Up 11.7%
    Recordati Reports Strong Momentum in H1 2025: Revenue Up 11.7%

    29 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/29/3123495/0/en/RECORDATI-STRONG-MOMENTUM-OF-THE-GROUP-CONTINUES-IN-THE-FIRST-HALF-OF-2025-REVENUE-11-7-EBITDA-1-9-6-ADJUSTED-NET-INCOME-2-8-9.html

    GLOBENEWSWIRE
    29 Jul 2025
    Share Share
    Amarin licenses Vazkepa to Recordati for Europe
    Amarin licenses Vazkepa to Recordati for Europe

    24 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/24/3104106/18362/en/Amarin-Announces-Exclusive-License-and-Supply-Agreement-with-Recordati-to-Commercialize-VAZKEPA-Icosapent-Ethyl-in-Europe.html

    GLOBENEWSWIRE
    24 Jun 2025
    Share Share
    Recordati Q1 2025 Revenue Up 11.9%, Profits Rise
    Recordati Q1 2025 Revenue Up 11.9%, Profits Rise

    08 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/08/3076994/0/en/RECORDATI-STRONG-MOMENTUM-OF-THE-GROUP-CONTINUES-INTO-THE-FIRST-QUARTER-OF-2025-REVENUE-11-9-EBITDA-1-10-7-ADJUSTED-NET-INCOME-2-7-2.html

    GLOBENEWSWIRE
    08 May 2025
    Share Share
    Recordati: 2025-2027 Plan Approved, Revenue Targets Set for 2027
    Recordati: 2025-2027 Plan Approved, Revenue Targets Set for 2027

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069542/0/en/RECORDATI-2025-2027-THREE-YEAR-PLAN-APPROVED-FY-2027-TARGETS-OF-REVENUE-BETWEEN-3-000-AND-3-200-MILLION-EBITDA-1-BETWEEN-1-140-AND-1-225-MILLION-ADJUSTED-NET-INCOME-2-BETWEEN-770-A.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Recordati: FDA Expands Isturisa Indication for Cushing's Syndrome
    Recordati: FDA Expands Isturisa Indication for Cushing's Syndrome

    16 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/16/3062342/0/en/RECORDATI-FDA-GRANTS-ISTURISA-OSILODROSTAT-EXPANDED-INDICATION-FOR-THE-TREATMENT-OF-ENDOGENOUS-HYPERCORTISOLEMIA-IN-PATIENTS-WITH-CUSHING-S-SYNDROME.html

    GLOBENEWSWIRE
    16 Apr 2025
    Share Share
    Angelini Pharma still keen on deals after failed Recordati bid
    Angelini Pharma still keen on deals after failed Recordati bid

    01 Apr 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/angelini-pharma-still-keen-deals-after-failed-recordati-bid-2025-04-01/

    REUTERS
    01 Apr 2025
    Share Share

    USDMF

    read-more
    read-more

    01

    Acyclovir

    Italy
    ESCRS
    Not Confirmed
    arrow

    02

    Alpha-methyldopa

    Italy
    ESCRS
    Not Confirmed
    arrow

    03

    Atenolol

    Italy
    ESCRS
    Not Confirmed
    arrow

    04

    Bromodiphenhydramine Hcl Bulk

    Italy
    ESCRS
    Not Confirmed
    arrow

    05

    Carbamazepine

    Italy
    ESCRS
    Not Confirmed
    arrow

    06

    Carglumic Acid

    Italy
    ESCRS
    Not Confirmed
    arrow

    07

    Cysteamine Bitartrate

    Italy
    ESCRS
    Not Confirmed
    arrow

    08

    Cysteamine Hydrochloride

    Italy
    ESCRS
    Not Confirmed
    arrow

    09

    Danazol

    Italy
    ESCRS
    Not Confirmed
    arrow

    10

    Dimenhydrinate

    Italy
    ESCRS
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Aciclovir

    CEP/COS

    ESCRS
    Not Confirmed
    arrow

    02

    Aciclovir, Process B

    CEP/COS

    ESCRS
    Not Confirmed
    arrow

    03

    Dimenhydrinate

    CEP/COS

    ESCRS
    Not Confirmed
    arrow

    04

    Diphenhydramine hydrochloride

    CEP/COS

    ESCRS
    Not Confirmed
    arrow

    05

    Dobutamine hydrochloride

    CEP/COS

    ESCRS
    Not Confirmed
    arrow

    06

    Fenticonazole nitrate

    CEP/COS

    ESCRS
    Not Confirmed
    arrow

    07

    Gemfibrozil

    CEP/COS

    ESCRS
    Not Confirmed
    arrow

    08

    Iopamidol

    CEP/COS

    ESCRS
    Not Confirmed
    arrow

    09

    Ketorolac trometamol

    CEP/COS

    ESCRS
    Not Confirmed
    arrow

    10

    Mebeverine hydrochloride

    CEP/COS

    ESCRS
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    JDMF

    read-more
    read-more

    01

    Acyclovir

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Acyclovir

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 217MF10746

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2005-10-07

    Latest Date of Registration : 2015-07-13

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Benidipine hydrochloride

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Benidipine hydrochloride

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 219MF10171

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2007-05-24

    Latest Date of Registration : 2007-05-24

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Cysteamine Hydrochloride

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Cysteamine Hydrochloride

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 305MF10060

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2023-05-17

    Latest Date of Registration : 2024-02-07

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Cysteamine Tartrate

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Cysteamine Tartrate

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 305MF10033

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2023-03-15

    Latest Date of Registration : 2023-03-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Dimenhydrinate

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Dimenhydrinate

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 217MF10747

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2005-10-07

    Latest Date of Registration : 2010-04-05

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Dopamine Hydrochloride

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Dopamine Hydrochloride

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 304MF10111

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2022-08-03

    Latest Date of Registration : 2022-08-03

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Karugurumin acid

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Karugurumin acid

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 227MF10276

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2015-12-11

    Latest Date of Registration : 2016-08-16

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Lansoprazole

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Lansoprazole

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 219MF10299

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2007-09-18

    Latest Date of Registration : 2007-09-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Papaverine Hydrochloride

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Papaverine Hydrochloride

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 231MF10018

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2019-01-29

    Latest Date of Registration : 2019-01-29

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Sertraline Hydrochloride

    JDMF

    ESCRS
    Not Confirmed
    arrow

    Sertraline Hydrochloride

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Recordati

    Registration Number : 226MF10095

    Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY

    Initial Date of Registration : 2014-05-14

    Latest Date of Registration : 2014-05-14

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-more

    01

    ACYCLOVIR

    Italy
    ESCRS
    Not Confirmed
    arrow

    ACYCLOVIR

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-9755

    Start Marketing Date : 1993-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    ACYCLOVIR

    Italy
    ESCRS
    Not Confirmed
    arrow

    ACYCLOVIR

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-9744

    Start Marketing Date : 2007-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (20kg/20kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    DIMENHYDRINATE

    Italy
    ESCRS
    Not Confirmed
    arrow

    DIMENHYDRINATE

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-4675

    Start Marketing Date : 1982-07-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    DIPHENHYDRAMINE CITRATE

    Italy
    ESCRS
    Not Confirmed
    arrow

    DIPHENHYDRAMINE CITRATE

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-4350

    Start Marketing Date : 2007-02-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    DIPHENHYDRAMINE HYDROCHLORIDE

    Italy
    ESCRS
    Not Confirmed
    arrow

    DIPHENHYDRAMINE HYDROCHLORIDE

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-4367

    Start Marketing Date : 1980-07-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    DOBUTAMINE HYDROCHLORIDE

    Italy
    ESCRS
    Not Confirmed
    arrow

    DOBUTAMINE HYDROCHLORIDE

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-4820

    Start Marketing Date : 1992-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    FLAVOXATE HYDROCHLORIDE

    Italy
    ESCRS
    Not Confirmed
    arrow

    FLAVOXATE HYDROCHLORIDE

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-5522

    Start Marketing Date : 2005-01-03

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    KETOROLAC TROMETHAMINE

    Italy
    ESCRS
    Not Confirmed
    arrow

    KETOROLAC TROMETHAMINE

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-5990

    Start Marketing Date : 2010-07-30

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    PAPAVERINE HYDROCHLORIDE

    Italy
    ESCRS
    Not Confirmed
    arrow

    PAPAVERINE HYDROCHLORIDE

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-7480

    Start Marketing Date : 2001-06-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    PHENYTOIN

    Italy
    ESCRS
    Not Confirmed
    arrow

    PHENYTOIN

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    NDC Package Code : 12711-4445

    Start Marketing Date : 1982-07-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    LISTED APIs

    read-more
    read-more
    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Aciclovir

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    01

    Aciclovir

    Italy
    ESCRS
    Not Confirmed
    arrow

    Aciclovir

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Benidipine Hydrochloride

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    02

    Benidipine Hydrochloride

    Italy
    ESCRS
    Not Confirmed
    arrow

    Benidipine Hydrochloride

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dimenhydrinate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    03

    Dimenhydrinate

    Italy
    ESCRS
    Not Confirmed
    arrow

    Dimenhydrinate

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Diphenhydramine Citrate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    04

    Diphenhydramine Citrate

    Italy
    ESCRS
    Not Confirmed
    arrow

    Diphenhydramine Citrate

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Diphenhydramine Hydrochloride

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    05

    Diphenhydramine Hydrochloride

    Italy
    ESCRS
    Not Confirmed
    arrow

    Diphenhydramine Hydrochloride

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dobutamine Hydrochloride

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    06

    Dobutamine Hydrochloride

    Italy
    ESCRS
    Not Confirmed
    arrow

    Dobutamine Hydrochloride

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dopamine

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    07

    Dopamine

    Italy
    ESCRS
    Not Confirmed
    arrow

    Dopamine

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ketorolac Trometamol

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    08

    Ketorolac Trometamol

    Italy
    ESCRS
    Not Confirmed
    arrow

    Ketorolac Trometamol

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lansoprazole

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    09

    Lansoprazole

    Italy
    ESCRS
    Not Confirmed
    arrow

    Lansoprazole

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Manidipine

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    10

    Manidipine

    Italy
    ESCRS
    Not Confirmed
    arrow

    Manidipine

    Italy
    arrow
    ESCRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of arou...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ALL Intermediates

    read-more
    read-more
    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    (R)-Tetrahydropapaverine

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    50896-90-7
    Cisatracurium Besylate
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    01

    (R)-Tetrahydropapaverine

    Italy
    ESCRS
    Not Confirmed
    arrow

    (R)-Tetrahydropapaverine

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    (R)-Tetrahydropapaverine

    CAS Number : 50896-90-7

    End Use API : Cisatracurium Besylate

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    (R)-Tetrahydropapaverine

    Intermediate Web Link

    Market Place

    50896-90-7
    Atracurium Besylate
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    02

    (R)-Tetrahydropapaverine

    Italy
    ESCRS
    Not Confirmed
    arrow

    (R)-Tetrahydropapaverine

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    (R)-Tetrahydropapaverine

    CAS Number : 50896-90-7

    End Use API : Atracurium Besylate

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Tetrahydropapaverine

    Intermediate Web Link

    Market Place

    6429-04-5
    Atracurium Besylate
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    03

    Tetrahydropapaverine

    Italy
    ESCRS
    Not Confirmed
    arrow

    Tetrahydropapaverine

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Tetrahydropapaverine

    CAS Number : 6429-04-5

    End Use API : Atracurium Besylate

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Homoveratric Acid

    Intermediate Web Link

    Market Place

    93-40-3
    Ivabradine Hydrochloride
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    04

    Homoveratric Acid

    Italy
    ESCRS
    Not Confirmed
    arrow

    Homoveratric Acid

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Homoveratric Acid

    CAS Number : 93-40-3

    End Use API : Ivabradine Hydrochloride

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Homoveratric Acid

    Intermediate Web Link

    Market Place

    93-40-3
    Atracurium Besylate
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    05

    Homoveratric Acid

    Italy
    ESCRS
    Not Confirmed
    arrow

    Homoveratric Acid

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Homoveratric Acid

    CAS Number : 93-40-3

    End Use API : Atracurium Besylate

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Homoveratric Acid

    Intermediate Web Link

    Market Place

    93-40-3
    Papaverine Hydrochloride
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    06

    Homoveratric Acid

    Italy
    ESCRS
    Not Confirmed
    arrow

    Homoveratric Acid

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Homoveratric Acid

    CAS Number : 93-40-3

    End Use API : Papaverine Hydrochloride

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Homoveratric Acid

    Intermediate Web Link

    Market Place

    93-40-3
    Atracurium Besylate
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    07

    Homoveratric Acid

    Italy
    ESCRS
    Not Confirmed
    arrow

    Homoveratric Acid

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Homoveratric Acid

    CAS Number : 93-40-3

    End Use API : Atracurium Besylate

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Homoveratronitrile

    Intermediate Web Link

    Market Place

    93-17-4
    Dobutamine Hydrochloride
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    08

    Homoveratronitrile

    Italy
    ESCRS
    Not Confirmed
    arrow

    Homoveratronitrile

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Homoveratronitrile

    CAS Number : 93-17-4

    End Use API : Dobutamine Hydrochloride

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Homoveratronitrile

    Intermediate Web Link

    Market Place

    93-17-4
    Verapamil
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    09

    Homoveratronitrile

    Italy
    ESCRS
    Not Confirmed
    arrow

    Homoveratronitrile

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Homoveratronitrile

    CAS Number : 93-17-4

    End Use API : Verapamil

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Homoveratronitrile

    Intermediate Web Link

    Market Place

    93-17-4
    Tetrabenazine
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stoc...
    Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America.
    blank

    10

    Homoveratronitrile

    Italy
    ESCRS
    Not Confirmed
    arrow

    Homoveratronitrile

    Italy
    ESCRS
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Recordati

    Homoveratronitrile

    CAS Number : 93-17-4

    End Use API : Tetrabenazine

    About the Company : Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters ...

    blank

    Intermediate Web Link

    Market Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA and get a quotation

    RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA is a supplier offers 51 products (APIs, Excipients or Intermediates).

    Find a price of Acyclovir bulk with DMF, CEP, JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Dimenhydrinate bulk with DMF, CEP, JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Verapamil Hydrochloride bulk with DMF, CEP, JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Carglumic Acid bulk with DMF, JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Cysteamine Bitartrate bulk with DMF, JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Cysteamine Hydrochloride bulk with DMF, JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Diphenhydramine Hydrochloride bulk with DMF, CEP offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Dobutamine Hydrochloride bulk with DMF, CEP offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Dopamine bulk with DMF, JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Ketorolac Trometamol bulk with DMF, CEP offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Tribenoside bulk with CEP, JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Fenticonazole Nitrate bulk with CEP offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Mebeverine bulk with CEP offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Papaverine Hydrochloride bulk with JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Sertraline Hydrochloride bulk with JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Benidipine Hydrochloride bulk with JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Diphenhydramine Citrate bulk with DMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Flavoxate bulk with DMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Gemfibrozil bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Iopamidol bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Lansoprazole bulk with JDMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Metoprolol Tartrate bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Osilodrostat Phosphate bulk with DMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Papaverine Hydrochloride bulk with DMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Phenytoin bulk with DMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Phenytoin Sodium bulk with DMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Pyridoxal Phosphate bulk with DMF offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Acyclovir bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Atenolol bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Bromazine Hydrochloride bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Carbamazepine bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Danazol bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Dipyridamole bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Disopyramide bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Fluoxetine Hydrochloride bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Fosphenytoin Sodium bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Gallopamil bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Ketoconazole bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Lovastatin bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Methyldopa bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Nabumetone bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Nimesulide bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Paroxetine Hydrochloride bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Terbinafine Hydrochloride bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Terfenadine bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Tramadol Hydrochloride bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of CHEMICAL FACTORY IN CAMPOVERDE DI APRILIA bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Manidipine bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Methenamine Hippurate bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Phenytoin bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Find a price of Tetrabenazine bulk offered by RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search